Zr-89 and PET Imaging for Theranostics

Theranostics (Therapy and Diagnostics) is a new targeted form of cancer treatment that is sweeping western medicine. Zr-89 is a positron-emitting isotope under investigation for use in the Diagnostic side of the new protocols. Dr. Metzger’s presentation at the recent Methods of Analytical Radiochemistry Conference entitled “Assessment of Long-Lived Contaminants in Zr-89 Labeled Monoclonal Antibodies” discusses Theranostics and the potential of Zr-89 in the dynamic PET imaging of monoclonal antibodies. The presentation can be found here.